# US 2022/0276231 A1 · Method for measuring beta-1,3-1,6-glucan

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0276231 A1
- Document ID: US20220276231A1
- Status: Published application
- Kind: A1
- Application number: 17/747,590
- Filed: 2022-05-18
- Published: 2022-09-01
- Earliest claimed: 2019-11-20
- Assignees: Olympus Corporation; Tokyo University of Pharmacy & Life Sciences
- Applicants: Olympus Corporation; Tokyo University of Pharmacy & Life Sciences
- Inventors: Hidetaka NAKATA; Yoshiyuki ADACHI; Kenichi ISHIBASHI; Daisuke YAMANAKA; Naohito OHNO
- Web page: https://patentgrep.com/patent/US20220276231A1

## CPC

- G01N 33/5308: {for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites}
- G01N 33/56961: {Plant cells or fungi}
- C07K 17/14: Peptides being immobilised on, or in, an inorganic carrier
- C12N 11/14: Enzymes or microbial cells immobilised on or in an inorganic carrier
- G01N 33/54326: {Magnetic particles}
- G01N 33/582: {with fluorescent label}
- G01N 33/543: with an insoluble carrier for immobilising immunochemicals
- G01N 2333/37: from fungi
- G01N 2400/24: beta-D-Glucans, i.e. having beta 1,n (n=3,4,6) linkages between saccharide units, e.g. xanthan
- G01N 2800/26: Infectious diseases, e.g. generalised sepsis
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention provides a method for quantitatively detecting β-1,3-1,6-glucan separately from β-1,3-glucan and β-1,3-1,4-glucan. The present invention is a method for measuring β-1,3-1,6-glucan, the method including: a step for mixing β-glucan in a test sample, a molecule that specifically binds to a β-(1→3) bond, and a molecule that specifically binds to a β-(1→6) bond to form a complex containing the molecule that specifically binds to a β-(1→3) bond and the molecule that specifically binds to a β-(1→6) bond; a step for detecting the complex; and a step for measuring the amount of β-1,3-1,6-glucan in the test sample, on the basis of the results of the detection.

## Claims

### Claim 1

A method for measuring β-1,3-1,6-glucan,
the method comprising:
a step for mixing a β-glucan in a test sample, a molecule that specifically binds to a β-(1→3) bond, and a molecule that specifically binds to a β-(1→6) bond to form a complex containing said molecule that specifically binds to a β-(1→3) bond and said molecule that specifically binds to a β-(1→6) bond;
a step for detecting said complex separately from a β-glucan bonded to only one of said molecule that specifically binds to a β-(1→3) bond and said molecule that specifically binds to a β-(1→6); and
a step for measuring an amount of β-1,3-1,6-glucan in said test sample based on a result of said detection.

### Claim 2 (depends on 1)

The method for measuring β-1,3-1,6-glucan according to claim 1,
wherein said molecule that specifically binds to a β-(1→6) bond is at least one selected from the group consisting of an enzyme-inactivated mutant of β-1,6-glucanase and an anti-β-1,6-glucan antibody.

### Claim 3 (depends on 1)

The method for measuring β-1,3-1,6-glucan according to claim 1,
wherein said molecule that specifically binds to a β-(1→3) bond is at least one selected from the group consisting of a horseshoe crab-derived factor G or a mutant thereof, a protein containing a carbohydrate recognition domain of dectin-1 or a mutant thereof, a β-glucan recognition protein or a mutant thereof, an enzyme-inactivated mutant of β-1,3-glucanase and an anti-β-1,3-glucan antibody.

### Claim 4 (depends on 1)

The method for measuring β-1,3-1,6-glucan according to claim 1,
wherein at least one of said molecule that specifically binds to a β-(1→3) bond and said molecule that specifically binds to a β-(1→6) bond is removed from said complex prior to the step for detecting said complex.

### Claim 5 (depends on 1)

The method for measuring β-1,3-1,6-glucan according to claim 1,
wherein at least one of said molecule that specifically binds to a β-(1→3) bond and said molecule that specifically binds to a β-(1→6) bond is labeled with a labeling material, and
detection of said complex is carried out by detecting a signal emitted from said labeling material.

### Claim 6 (depends on 5)

The method for measuring β-1,3-1,6-glucan according to claim 5,
wherein one of said molecule that specifically binds to a β-(1→3) bond and said molecule that specifically binds to a β-(1→6) bond is labeled with said labeling material, while the other is immobilized on a solid phase support.

### Claim 7 (depends on 6)

The method for measuring β-1,3-1,6-glucan according to claim 6, wherein said solid phase support is a magnetic bead.

### Claim 8 (depends on 6)

The method for measuring β-1,3-1,6-glucan according to claim 6,
wherein said solid phase support is modified with a biotin-binding molecule, and
among said molecule that specifically binds to a β-(1→3) bond and said molecule that specifically binds to a β-(1→6) bond, the molecule immobilized on said solid phase support is a biotin-modified molecule.

### Claim 9 (depends on 5)

The method for measuring β-1,3-1,6-glucan according to claim 5, wherein said labeling material is a luminescent material.

### Claim 10 (depends on 9)

The method for measuring β-1,3-1,6-glucan according to claim 9, wherein said labeling material is a fluorescent material.

### Claim 11 (depends on 1)

The method for measuring β-1,3-1,6-glucan according to claim 1, wherein said complex is detected by a scanning single-molecule counting method.

### Claim 12 (depends on 1)

A method for evaluating a likelihood of fungal infection,
the method comprising:
a step for performing the method for measuring β-1,3-1,6-glucan according to claim 1 using a biological sample collected from a test animal as a test sample to measure an amount of β-1,3-1,6-glucan in said test sample; and
a step for evaluating a likelihood of infection of said test animal with a fungus based on an amount of β-1,3-1,6-glucan in said test sample obtained by said measurement.

### Claim 13

A kit for measuring β-1,3-1,6-glucan,
the kit comprising a molecule that specifically binds to a β-(1→3) bond and a molecule that specifically binds to a β-(1→6) bond, wherein
either one of said molecules is bindable to a solid phase support, and the other one binds to a labeling material which is detectable.
